Metabolic Profiling Reveals PAFAH1B3 as a Critical Driver of Breast Cancer Pathogenicity

Bachovchin, 2011, Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors, Proc. Natl. Acad. Sci. USA, 108, 6811, 10.1073/pnas.1015248108

Benjamin, 2012, Global profiling strategies for mapping dysregulated metabolic pathways in cancer, Cell Metab., 16, 565, 10.1016/j.cmet.2012.09.013

Chaffer, 2011, A perspective on cancer cell metastasis, Science, 331, 1559, 10.1126/science.1203543

Chakravarthy, 2009, Identification of a physiologically relevant endogenous ligand for PPARalpha in liver, Cell, 138, 476, 10.1016/j.cell.2009.05.036

Chambers, 2002, Dissemination and growth of cancer cells in metastatic sites, Nat. Rev. Cancer, 2, 563, 10.1038/nrc865

Chan, 2011, The Hippo pathway in biological control and cancer development, J. Cell. Physiol., 226, 928, 10.1002/jcp.22435

Chang, 2011, A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis, Chem. Biol., 18, 476, 10.1016/j.chembiol.2011.02.008

Chao, 2012, Programmed cell removal: a new obstacle in the road to developing cancer, Nat. Rev. Cancer, 12, 58, 10.1038/nrc3171

Chiang, 2006, An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling, Chem. Biol., 13, 1041, 10.1016/j.chembiol.2006.08.008

Cordenonsi, 2011, The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells, Cell, 147, 759, 10.1016/j.cell.2011.09.048

Gupta, 2009, Identification of selective inhibitors of cancer stem cells by high-throughput screening, Cell, 138, 645, 10.1016/j.cell.2009.06.034

Györffy, 2010, An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients, Breast Cancer Res. Treat., 123, 725, 10.1007/s10549-009-0674-9

Hattori, 1995, Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol, J. Biol. Chem., 270, 22308, 10.1074/jbc.270.38.22308

Hong, 2012, The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway, Semin. Cell Dev. Biol., 23, 785, 10.1016/j.semcdb.2012.05.004

Huang, 2013, The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism, Biochim. Biophys. Acta, 1831, 1555, 10.1016/j.bbalip.2013.04.012

Jessani, 2004, Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo, Proc. Natl. Acad. Sci. USA, 101, 13756, 10.1073/pnas.0404727101

Kelly, 2005, Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy, Drug Resist. Updat., 8, 51, 10.1016/j.drup.2005.03.002

Kopp, 2010, The glycerophospho metabolome and its influence on amino acid homeostasis revealed by brain metabolomics of GDE1(-/-) mice, Chem. Biol., 17, 831, 10.1016/j.chembiol.2010.06.009

Lamar, 2012, The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain, Proc. Natl. Acad. Sci. USA, 109, E2441, 10.1073/pnas.1212021109

Liang, 2013, Differential Effects on Lung Cancer Cell Proliferation by Agonists of Glucocorticoid and PPARα Receptors, Mol. Carcinog.

Long, 2011, The metabolic serine hydrolases and their functions in mammalian physiology and disease, Chem. Rev., 111, 6022, 10.1021/cr200075y

Manya, 1999, Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase, J. Biol. Chem., 274, 31827, 10.1074/jbc.274.45.31827

Menendez, 2007, Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis, Nat. Rev. Cancer, 7, 763, 10.1038/nrc2222

Morad, 2013, Ceramide-orchestrated signalling in cancer cells, Nat. Rev. Cancer, 13, 51, 10.1038/nrc3398

Nomura, 2010, Activity-based protein profiling for biochemical pathway discovery in cancer, Nat. Rev. Cancer, 10, 630, 10.1038/nrc2901

Nomura, 2010, Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis, Cell, 140, 49, 10.1016/j.cell.2009.11.027

Nomura, 2011, Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer, Chem. Biol., 18, 846, 10.1016/j.chembiol.2011.05.009

National Cancer Institute. (2013). Drugs approved for breast cancer. http://www.cancer.gov/cancertopics/druginfo/breastcancer.

Polyak, 2009, Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits, Nat. Rev. Cancer, 9, 265, 10.1038/nrc2620

Pozzi, 2008, PPARalpha Ligands as Antitumorigenic and Antiangiogenic Agents, PPAR Res., 2008, 906542, 10.1155/2008/906542

Puustinen, 2009, PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma, Cancer Res., 69, 2870, 10.1158/0008-5472.CAN-08-2760

Rual, 2005, Towards a proteome-scale map of the human protein-protein interaction network, Nature, 437, 1173, 10.1038/nature04209

Santner, 2001, Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells, Breast Cancer Res. Treat., 65, 101, 10.1023/A:1006461422273

Santos, 2009, Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice, J. Clin. Invest., 119, 3613, 10.1172/JCI38988

Spandidos, 2010, PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification, Nucleic Acids Res., 38, D792, 10.1093/nar/gkp1005

Sweeney, 2000, Lissencephaly associated mutations suggest a requirement for the PAFAH1B heterotrimeric complex in brain development, Mech. Dev., 92, 263, 10.1016/S0925-4773(00)00242-2

Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809

Yang, 2013, Oncometabolites: linking altered metabolism with cancer, J. Clin. Invest., 123, 3652, 10.1172/JCI67228